These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 3087166)

  • 21. Therapy of Klebsiella pneumoniae septicaemia in neutropenic rats.
    Magliulo E; Piantieri G; Cafarelli A; Cruciani M
    Pharmatherapeutica; 1982; 3(2):114-8. PubMed ID: 7048337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Infection in neutropenic cancer patients--etiology, microbiological diagnostics, treatment].
    Durnaá B; Dzierzanowska D
    Wiad Lek; 2006; 59(7-8):506-11. PubMed ID: 17209349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination therapy against multidrug-resistant bacteria].
    Araoka H
    Nihon Rinsho; 2012 Feb; 70(2):305-10. PubMed ID: 22413536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial therapy for two serious bacterial infections. Enterococcal endocarditis and nosocomial pneumonia.
    Sande MA
    Arch Intern Med; 1982 Oct; 142(11):2033-4. PubMed ID: 7125791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.
    Sande MA; Brooks-Fournier RA; Gerberding JL
    Am J Med; 1987 Apr; 82(4A):63-6. PubMed ID: 3578331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gram-positive bacterial infections resistant to antibiotic treatment].
    Utili R
    Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New therapeutic approaches to hospital-acquired pneumonia.
    Pennington JE
    Semin Respir Infect; 1987 Mar; 2(1):67-73. PubMed ID: 3321267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
    Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Licci A; Nadolski P; Riva A; Lukasiak J; Scalise G
    Int J Antimicrob Agents; 2005 Sep; 26(3):235-40. PubMed ID: 16122911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections.
    Isenberg HD; Sampson-Scherer J; Cleeland R; Titsworth E; Beskid G; Christenson JG; DeLorenzo WF; Unowsky J
    Crit Rev Microbiol; 1982; 10(1):1-76. PubMed ID: 6756787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bacterial endocarditis. Clinical picture, treatment and course in 37 patients (author's transl)].
    Lode H; Behn B; Langmaack H; Schröder R
    Dtsch Med Wochenschr; 1977 Apr; 102(16):599-606. PubMed ID: 404127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model.
    Gudmundsson S; Einarsson S; Erlendsdottir H; Moffat J; Bayer W; Craig WA
    J Antimicrob Chemother; 1993 May; 31 Suppl D():177-91. PubMed ID: 8335520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections.
    Gerber AU
    Scand J Infect Dis Suppl; 1990; 74():147-54. PubMed ID: 2097702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro models for the study of combination antibiotic therapy in neutropenic patients.
    Zinner SH; Dudley M; Blaser J
    Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of aminoglycosides in immunocompromised patients.
    Young LS
    Am J Med; 1985 Jul; 79(1A):21-7. PubMed ID: 4025366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a glycopeptide antibiotic, teicoplanin, in the treatment of septicaemia caused by gram-positive bacteria.
    Webster A; Wilson AP; Treasure T; Grüneberg RN
    Int J Clin Pharmacol Res; 1988; 8(2):95-8. PubMed ID: 2967800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
    DeJace P; Klastersky J
    Am J Med; 1986 Jun; 80(6B):29-38. PubMed ID: 3524218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination antibiotic therapy in pediatrics.
    Chadwick EG; Yogev R; Shulman ST
    Am J Med; 1986 Jun; 80(6B):166-71. PubMed ID: 3728528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination antibiotic therapy of bacterial endocarditis.
    Sande MA; Scheld WM
    Ann Intern Med; 1980 Mar; 92(3):390-5. PubMed ID: 6986829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy with combinations of aminoglycosides and other antibiotics].
    Stille W
    Adv Clin Pharmacol; 1978; 15():127-40. PubMed ID: 676871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.